Indication
Staphylococcal Skin Infections
2 clinical trials
3 products
Product
DalbavancinClinical trial
A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure InfectionsStatus: Completed, Estimated PCD: 2023-12-31
Product
ComparatorClinical trial
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military TraineesStatus: Completed, Estimated PCD: 2012-01-01
Product
Chlorhexidine gluconate